Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA
Read More 8 minute read Pharma Industry News Gilead Sciences bets $2.2bn on immune reset with Ouro Medicines BCMAxCD3 bispecific acquisition Gilead Sciences agrees to acquire Ouro Medicines for up to $2.175bn, adding BCMA T cell engager gamgertamig to its inflammation pipeline. Read the full strategic analysis. byVenkateshMarch 24, 2026